Preeclampsia and Site-Specific Cancer Risk: A Nationwide Population-Based Study

Area of Science:

• Obstetrics and Gynecology
• Oncology
• Epidemiology

Background:

• Preeclampsia is a pregnancy complication characterized by high blood pressure.
• It is associated with microangiopathy and potential links to cancer development.
• Evaluating cancer risk in preeclamptic women is crucial for understanding long-term health outcomes.

Purpose of the Study:

• To investigate the association between newly diagnosed preeclampsia and subsequent cancer risk.
• To identify specific cancer types with altered risk profiles in women with a history of preeclampsia.

Main Methods:

• A nationwide, population-based retrospective cohort study utilizing Korean National Health Insurance claims data (2008-2020).
• Comparison of cancer incidence between women diagnosed with preeclampsia (2009-2013) and a control group (appendectomy without preeclampsia).
• Exclusion of participants with prior cancer diagnoses; cancer occurrence assessed via ICD-10 codes.

Main Results:

• Analysis included 42,380 preeclampsia patients and 105,327 controls.
• Preeclampsia was associated with significantly higher risks of gallbladder/biliary tract, breast, and thyroid cancers.
• Conversely, preeclampsia showed decreased risks for ovarian cancer and leukemia.

Conclusions:

• Preeclampsia is linked to an increased risk of specific cancers, notably breast and thyroid cancer.
• A decreased risk for ovarian cancer and leukemia was observed in women with preeclampsia.
• Age-adjusted hazard ratios are primary findings due to age differences between groups; some associations require replication.